Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 25/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

100%

2 of 2 completed trials have results

Key Signals

1 recruiting2 with results

Enrollment Performance

Analytics

N/A
2(50.0%)
Phase 2
2(50.0%)
4Total
N/A(2)
Phase 2(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT06424119Not ApplicableRecruiting

Multi-Center Study of Clinical and Inflammatory Outcomes in Intensive Cardiac Rehabilitation and Traditional Cardiac Rehabilitation Programs

Role: collaborator

NCT04212962Not ApplicableUnknown

Transitional Care Model Evaluation 2020

Role: collaborator

NCT04824365Phase 2Completed

Sodium Pyruvate Nasal Spray Treatment of COVID-19 Infection

Role: collaborator

NCT04871815Phase 2Completed

Effects of Sodium Pyruvate Nasal Spray in COVID-19 Long Haulers.

Role: collaborator

All 4 trials loaded